EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS

Steven Deitelzweig,Allison Keshishian,Amiee Kang,Amol Dhamane,Xuemei Luo,Xiaoyan Li,Neeraja Balachander,Lisa Rosenblatt,Jack Mardekian,Xianying Pan,Manuela Di Fusco,Alessandra Bassalobre Garcia,Huseyin Yuce,Gregory Y.H. Lip

EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS

2019

Steven Deitelzweig
Allison Keshishian
Amiee Kang
Amol Dhamane
Xuemei Luo
Xiaoyan Li
Neeraja Balachander
Lisa Rosenblatt
Jack Mardekian
Xianying Pan
Manuela Di Fusco
Alessandra Bassalobre Garcia
Huseyin Yuce
Gregory Y.H. Lip

Obesity has an important impact on general health outcomes and is prevalent in nonvalvular atrial fibrillation (NVAF) patients. This study evaluated stroke/systemic embolism (SE) and major bleeding (MB) among obese NVAF patients using non-vitamin K antagonist oral anticoagulants (NOACs) in the

Keywords:

Obesity
Antagonist
Embolism
Atrial fibrillation
Vitamin K antagonist
Cardiology
Stroke
Medicine
Internal medicine
Diabetes mellitus
general health
claims database

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations